Global Tumor Ablation Market to reach USD 1045.35 million by 2026

Global Tumor Ablation Market Size study, by Technology (Radiofrequency, Microwave, Cryoablation, Others), by Mode of Treatment (Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation), by Application (Liver Cancer, Lung Cancer, Kidney Cancer, Others) and Regional Forecasts 2019-2026
Product Code:  HALDAT_72855879
Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Million)
1.2.1.	Tumor Ablation Market, by Technology, 2017-2026 (USD Million) 
1.2.2.	Tumor Ablation Market, by Mode of Treatment, 2017-2026 (USD Million)
1.2.3.	Tumor Ablation Market, by Application, 2017-2026 (USD Million)
1.2.4.	Tumor Ablation Market, by Region, 2017-2026 (USD Million)
1.3.	Key Trends
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Tumor Ablation Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Scope of the Study
2.2.2.	Industry Evolution
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Tumor Ablation Market Dynamics	
3.1.	Tumor Ablation Market Impact Analysis (2018-2026)
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Global Tumor Ablation Market: Industry Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Suppliers
4.1.2.	Bargaining Power of Buyers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2.	PEST Analysis
4.2.1.	Political 
4.2.2.	Economical
4.2.3.	Social 
4.2.4.	Technological 
4.3.	Investment Adoption Model
4.4.	Analyst Recommendation & Conclusion
Chapter 5.	Global Tumor Ablation Market, by Technology 
5.1.	Market Snapshot 
5.2.	Global Tumor Ablation Market by Technology, Performance - Potential Analysis
5.3.	Global Tumor Ablation Market Estimates & Forecasts by Technology 2016-2026 (USD Million)
5.4.	Tumor Ablation Market, Sub Segment Analysis 
5.4.1.	Radiofrequency
5.4.2.	Microwave
5.4.3.	Cryoablation
5.4.4.	Others
Chapter 6.	Global Tumor Ablation Market, by Mode of Treatment 
6.1.	Market Snapshot 
6.2.	Global Tumor Ablation Market by Mode of Treatment, Performance - Potential Analysis
6.3.	Global Tumor Ablation Market Estimates & Forecasts by Mode of Treatment, 2016-2026 (USD Million)
6.4.	Tumor Ablation Market, Sub Segment Analysis
6.4.1.	Surgical Ablation
6.4.2.	Laparoscopic Ablation
6.4.3.	Percutaneous Ablation
Chapter 7.	Global Tumor Ablation Market, by Application 
7.1.	Market Snapshot 
7.2.	Global Tumor Ablation Market by Application, Performance - Potential Analysis
7.3.	Global Tumor Ablation Market Estimates & Forecasts by Application, 2016-2026 (USD Million)
7.4.	Tumor Ablation Market, Sub Segment Analysis
7.4.1.	Liver Cancer
7.4.2.	Lung Cancer
7.4.3.	Kidney Cancer
7.4.4.	Others
Chapter 8.	Global Tumor Ablation Market, Regional Analysis
8.1.	Tumor Ablation Market, Regional Market Snapshot 
8.2.	North America Tumor Ablation Market 
8.2.1.	U.S. Tumor Ablation Market	Technology breakdown estimates & forecasts, 2016-2026	Mode of Treatment breakdown estimates & forecasts, 2016-2026	Application breakdown estimates & forecasts, 2016-2026
8.2.2.	Canada Tumor Ablation Market
8.3.	Europe Tumor Ablation Market Snapshot
8.3.1.	U.K. Tumor Ablation Market 
8.3.2.	Rest of Europe Tumor Ablation Market
8.4.	Asia-Pacific Tumor Ablation Market Snapshot
8.4.1.	China Tumor Ablation Market 
8.4.2.	India Tumor Ablation Market 
8.4.3.	Japan Tumor Ablation Market
8.4.4.	Rest of Asia Pacific Tumor Ablation Market
8.5.	Latin America Tumor Ablation Market Snapshot
8.5.1.	Brazil Tumor Ablation Market
8.5.2.	Mexico Tumor Ablation Market
8.6.	Rest of The World Tumor Ablation Market
Chapter 9.	Competitive Intelligence
9.1.	Top Market Strategies
9.2.	Company Profiles
9.2.1.	Medtronic, PLC.	Key Information	Overview	Financial (Subject To Data Availability)	Product Summary	Recent Developments
9.2.2.	Angiodynamics, Inc.
9.2.3.	Healthtronics, Inc.
9.2.4.	Galil Medical, Inc.
9.2.5.	Boston Scientific Corporation
9.2.6.	Neuwave Medical, Inc.
9.2.7.	Edap Tms S.A.
9.2.8.	Mermaid Medical A/S
9.2.9.	Sonacare Medical, LLC
9.2.10.	Misonix, Inc.
Chapter 10.	Research Process
10.1.	Research Process
10.1.1.	Data Mining
10.1.2.	Analysis
10.1.3.	Market Estimation
10.1.4.	Validation
10.1.5.	Publishing
10.2.	Research Attributes
10.3.	Research Assumption

Global Tumor Ablation Market is valued approximately at USD 407.42 million in 2018 and is anticipated to grow with a healthy growth rate of more than 12.5% over the forecast period 2019-2026. Tumor ablation is a minimally invasive technique which is usually used in the treatment of tumors of the bone, kidneys, liver and lungs. At the time of tumor ablation, thermal energy is used to cool or heat tissue to cytotoxic levels (below −40°C or over 60°C). It is a vital option for the people who have failed chemotherapy or radiotherapy or are not surgical candidates. Ablation is also being observed as a potential first-line treatment in many patients with small hepatocellular carcinomas or benign tumors in the liver. Increasing incidences of cancer, growing geriatric population, technological advancements in ablation devices and surging government programs to reduce the cancer incidence are the few factors responsible for high CAGR of the market over the forecast period. For instance, in 2018, it was estimated that there were 17.0 million new cancer cases and 9.5 million deaths due to cancer worldwide. The global burden of cancer is expected to grow to 27.5 million new cancer cases and 16.3 million cancer deaths by 2040 due to the growth and aging of the population, according to the International Agency for Research on Cancer (IARC). Moreover, growing awareness about ablation procedures over conventional therapeutic and surgical procedures is another the major factor which creates lucrative growth opportunities to the growth of market in the upcoming years. However, cost containment measures taken by various governments and long approval time for the product launch are the few factors anticipated to restrain the growth of global Tumor Ablation market during the forecast period.

The regional analysis of global Tumor Ablation Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the increasing acceptance of tumor ablation products due to rising prevalence of cancer, surging inclination of patients towards minimally invasive procedures and increasing government funding for cancer research in the region. However, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as improving healthcare infrastructure, increasing number of cancer patients and growing government assistance programs to reduce cancer incidence would fuel-up the adoption of Tumor Ablation in the Asia-Pacific region.

Major market player included in this report are:
Medtronic, PLC.
Angiodynamics, Inc.
Healthtronics, Inc.
Galil Medical, Inc.
Boston Scientific Corporation
Neuwave Medical, Inc.
Edap Tms S.A.
Mermaid Medical A/S
Sonacare Medical, LLC
Misonix, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology:

By Mode of Treatment:
Surgical Ablation
Laparoscopic Ablation
Percutaneous Ablation

By Application:
Liver Cancer
Lung Cancer
Kidney Cancer

By Region:
North America
Asia Pacific
Latin America
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Tumor Ablation Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.